Newtyn Management’s scPharmaceuticals SCPH Stock Holding History

Newtyn Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-940,568	Closed	-$5.33M	–	39
2025 Q3	$5.33M	Buy	+940,568	New	+$4.82M	0.65%	28

Newtyn Management's SCPH Position: Q4 2025 in Review

Newtyn Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 940,568 shares — an estimated $5.33M sold.

Newtyn Management first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $5.33M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Newtyn Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Newtyn Management sold 940,568 scPharmaceuticals shares in Q4 2025, an estimated $5.33M.
Newtyn Management first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
Newtyn Management's scPharmaceuticals position peaked at $5.33M in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Newtyn Management's 13F filing for Q4 2025, filed 17 Feb 2026.